Compare GNE & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNE | NAGE |
|---|---|---|
| Founded | 2011 | 1999 |
| Country | United States | United States |
| Employees | N/A | 117 |
| Industry | Power Generation | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 350.3M | 350.8M |
| IPO Year | 2011 | N/A |
| Metric | GNE | NAGE |
|---|---|---|
| Price | $14.79 | $4.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $16.00 | $16.00 |
| AVG Volume (30 Days) | 42.2K | ★ 642.2K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | ★ 95.65 | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $425,202,000.00 | N/A |
| Revenue This Year | $17.49 | $16.51 |
| Revenue Next Year | $7.07 | $14.58 |
| P/E Ratio | ★ $15.88 | $21.29 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.19 | $4.16 |
| 52 Week High | $28.47 | $14.66 |
| Indicator | GNE | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 62.26 | 36.74 |
| Support Level | $14.71 | N/A |
| Resistance Level | $14.85 | $6.90 |
| Average True Range (ATR) | 0.53 | 0.22 |
| MACD | 0.11 | -0.03 |
| Stochastic Oscillator | 91.12 | 16.34 |
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.